KRISTIN HADDOCK: Open Payments
NPI 1053384073 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 20 payments from 10 companies in 2025. Trend: 2023 $634 · 2024 $598 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| ABBVIE INC. | 3 | $62 |
| Astellas Pharma US Inc | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Abbott Laboratories | 1 | $25 |
| Globus Medical, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: LEQVIO, Ozempic, VRAYLAR, Veozah, Wegovy, FREESTYLE LIBRE 3, Senza, MOUNJARO.
Industry payments across SC — which companies pay providers there.
